58 results
S-8
EX-99.3
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
be approved by the Company’s independent compensation committee or a majority of the Company’s independent directors (as defined in Nasdaq Stock Market Rule … of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event
8-K
EX-1.1
umi 6050s782yi2tq0j
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
5a1gos7b06qgyjle9ob
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
yb0d3to
28 Nov 23
Prospectus supplement for primary offering
4:25pm
S-3ASR
EX-4.6
00xytvdo
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
3ct3z7lts6zi
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.5
mix 14z36
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.7
vahh6gaqi6fyfx
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.4
7d5ae8gfe50iy
23 Sep 22
Automatic shelf registration
4:08pm
8-K
EX-1.1
7zkfv0bkskl
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
8kb1v1 7vh7
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
ry8vcsycoq3zsv9shq
20 Jul 22
Prospectus supplement for primary offering
4:22pm